Neuropilin and Neuropilin Associated Molecules as New Molecular Targets in Pancreatic Adenocarcinoma

Author(s): Michael H. Muders

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 11 , Issue 5 , 2011

Become EABM
Become Reviewer
Call for Editor


The Neuropilin receptors are increasingly recognized as receptors for vascular endothelial growth factors like VEGF-A and VEGF-C as well as other important growth factors like HGF and FGF in human vasculature and in tumor cells. More and more studies show an important role of Neuropilin in cancer biology suggesting that these transmembrane proteins might be an emerging target for new therapies in different subsets of cancer. Interestingly, blocking the adaptor protein GIPC1/Synectin that interacts with Neuropilin might be another interesting avenue for therapy. This review summarizes unfolding scientific data on these receptors and its interacting protein GIPC1/Synectin as molecular targets for therapy in pancreatic ductal adenocarcinoma.

Keywords: GIPC1, neuropilin-1, neuropilin-2, pancreatic cancer, synectin, targeted therapy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [442 - 447]
Pages: 6
DOI: 10.2174/187152011795677481
Price: $65

Article Metrics

PDF: 11